Safeguarding Patients and Taxpayers Act
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Safeguarding Patients and Taxpayers Act
This bill requires the Centers for Medicare & Medicaid Services (CMS) to annually report certain information on its use of funds to implement the Medicare Drug Price Negotiation Program. (The program requires the CMS to negotiate the prices of certain prescription drugs under Medicare beginning in 2026.)
Specifically, the CMS must annually report (for as long as funds are available) on the amounts expended, the use of funds, and the projected and actual unused funds from amounts appropriated to implement the program. The CMS must also report on relevant contracts, efforts to prevent fraud, waste, and abuse, and other implementation activities and associated expenditures.
The bill also explicitly restricts the CMS from using program funds for other programs or purposes.
Read twice and referred to the Committee on Finance.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 1589: Safeguarding Patients and Taxpayers Act. 118th Congress. Open America. https://openamerica.io/bill/118-S-1589/
"S. 1589: Safeguarding Patients and Taxpayers Act." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-S-1589/.
S. 1589, 118th Cong. (2026), https://openamerica.io/bill/118-S-1589/.
[S. 1589: Safeguarding Patients and Taxpayers Act](https://openamerica.io/bill/118-S-1589/)